Ibuprofen Banner (Ibuprofen)

Ibuprofen blocks the activity of cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for the production of prostaglandins. By lowering prostaglandin levels, it reduces inflammation, lowers body temperature, and alleviates pain at the site of injury or infection.

The appropriate dose of Ibuprofen Banner is determined by a qualified healthcare professional based on the individual’s age, weight, condition being treated, and overall health status. Patients should follow the prescriber’s instructions and the product label.

Safety data for ibuprofen use in pregnancy, especially in the third trimester, are limited, and the drug may affect fetal renal function. Breastfeeding mothers should consult a healthcare provider, as ibuprofen can pass into breast milk in small amounts.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Ibuprofen Banner provides both analgesic and anti‑inflammatory effects, whereas acetaminophen primarily offers pain relief and fever reduction without significant anti‑inflammatory activity. Ibuprofen may be preferred for conditions involving inflammation, but it carries a higher risk of gastrointestinal and renal side effects compared with acetaminophen.

Store Ibuprofen Banner at ambient temperature, preferably below 25 °C. Keep the tablets in their original container, protect them from moisture, direct sunlight, and excessive heat to maintain product stability.

Ibuprofen Banner is taken orally with a full glass of water. It can be taken with or without food; however, taking it with food or milk may reduce the likelihood of stomach irritation.

Serious risks include gastrointestinal bleeding or ulceration, kidney injury, severe allergic reactions such as anaphylaxis, and increased cardiovascular events in high‑risk individuals. Patients should seek immediate medical attention if they notice signs of bleeding, severe rash, swelling, or difficulty breathing.

Individuals with a known hypersensitivity to ibuprofen or other NSAIDs, active gastrointestinal ulcers, severe heart failure, uncontrolled hypertension, or those on anticoagulant therapy without medical supervision should avoid using Ibuprofen Banner. Consultation with a healthcare professional is essential before starting therapy.